Form 4: Fulgent Genetics President and COO Sells Shares for Tax Obligations

Jian Xie, President and COO of Fulgent Genetics, Inc., sold 1,873 shares of common stock on May 27, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Jian Xie, President and Chief Operating Officer of Fulgent Genetics, Inc. (FLGT), reported the sale of common stock.
• On May 27, 2025, Mr. Xie sold 690 shares at a weighted-average price of $20.5753 per share.
• Additionally, on the same date, he sold 1,183 shares at a weighted-average price of $20.5169 per share.
• The total number of shares sold was 1,873.
• These sales were conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted on February 23, 2023, and February 26, 2024.
• Following these transactions, Mr. Xie directly beneficially owns 372,631 shares of common stock.
• An additional 220,816 shares are indirectly beneficially owned through The Hsieh Family Dynasty Trust, dated January 27, 2010, where Mr. Xie serves on the investment committee.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale reduces ownership, the stated reason (tax withholding on RSU vesting) is a common, non-discretionary event and typically does not signal a lack of confidence in the company's future performance.

Positives

• The sales were for tax withholding purposes related to RSU vesting, which is a common and often pre-planned, non-discretionary event, not indicative of a change in management's outlook on the company.

Negatives

• The transactions resulted in a reduction of direct beneficial ownership by the President and COO, though the reason for the sale mitigates the negative signal.

Risks

• No specific risks are detailed in this Form 4 filing beyond the inherent nature of insider transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, specifically for tax withholding purposes, and does not provide broader industry context or trends. Such transactions are common across all industries when restricted stock units vest.

Related Party Transactions

• Shares are indirectly held by The Hsieh Family Dynasty Trust, dated January 27, 2010, where Mr. Xie serves on the investment committee. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

Stakeholder Impact

• Shareholders: The sale of a small number of shares for tax purposes by an executive is a routine event and is unlikely to have a significant impact on shareholder sentiment or the company's stock price.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

Fulgent Genetics, FLGT, Form 4, insider transaction, stock sale, restricted stock units, RSU, tax withholding, Jian Xie, beneficial ownership